Posology : מינונים

4.2    Posology and method of administration
Femoston 1/10 mg is indicated for the treatment of symptoms and not for prevention.

Femoston 1/10 mg is taken orally daily according to a continuous sequential regimen, as described below.

For each cycle of 28 days for the first 14 days one white tablet with estradiol is taken once a day and for the following 14 days one grey tablet with estradiol and dydrogesterone is taken once a day, as indicated on the calendar pack for 28 days.
After a cycle of 28 days on the 29th day a new cycle of 28 days begins. The treatment cycles therefore follow one another without a break.

For the treatment of estrogen deficiency in postmenopausal women as an initial and maintenance dose the lowest effective dose should be used and the duration of treatment period should be kept as short as possible (see also section 4.4). In case of no improvement of symptoms within 3 months, treatment should be stopped.

In general sequential combined treatment should be started with Femoston 1/10 mg.
Depending on the clinical response the dose can be adjusted accordingly.

In women who are not taking hormone replacement therapy or in women switching from continuous combined hormone replacement therapy, the treatment can be started on any convenient day. In women switching from cyclical or continuous sequential hormone replacement therapy, treatment should start on the day immediately after completion of the previous cycle.

If a tablet is missed it is recommended to take the next tablet without taking the forgotten tablet. Forgetting a tablet may increase the chance of breakthrough bleeding or spotting.

Femoston 1/10 mg can be taken both with and without food.

Paediatric patients:
There are no relevant indications for the use of Femoston 1/10 mg in the paediatric patients.